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1. INTRODUCTION 
Hybridoma cells producing monoclonal anti- 
bodies can be obtained from immunoglobulin-pro- 
ducing B-lymphocytes hybridised with a perma- 
nent cell line of myeloma cells [l-3]. Monoclonal 
antibodies obtained from mouse hybridoma cells 
are useful for a variety of diagnostic purposes and 
for the preparation of natural products of bio- 
technological interest. The application of these 
antibodies to humans in immunotherapy is limited 
[4] due to possible adverse interspecies reactions. 
Since an immunisation regime would be quite un- 
reasonable in the human system, the number of 
lymphocytes with a specificity against a particular 
determinant is relatively low. A fusion method 
with a particularly high yield of hybridised cells is, 
thus, a prerequisite for the successful preparation 
of hybridised cells which are capable of producing 
antibodies with a given specificity. 
The production of hybridoma cells using human 
B-lymphocytes and human myeloma cells, has 
been done in [5,6]. As in the case of mouse 
hybridoma cells, fusion was achieved by the aid of 
PEG. The yield of hybridoma cells produced after 
the application of the PEG-induced fusion tech- 
Abbreviations: AC, alternating current; DMEM, 
Dulbecco’s modified Eagle’s medium; FCS. Fetal calf- 
serum; F530 (DNA), intensity of green fluorescence 
emission (530 nm) corresponding to DNA content; 
HAT-medium, selection medium, containing hypox- 
anthine, aminopterin and thymidine; PEG. poly- 
ethylene glycol 
nique is very low, which is a considerable disad- 
vantage. Moreover, the selection of hybridoma 
cells obtained by this method requires the use of 
HAT-sensitive myeloma cells [7], since the fusion 
process cannot be optically followed and the re- 
sulting hybridoma cells have to be selected via the 
HAT minimal medium. 
Here, we report on the production of hybridoma 
cells with the aid of the electro-fusion technique 
[8-l 11. This method has the special advantage that 
yields are high, and that the fusion process can be 
followed under the microscope, so that the result- 
ing hybridoma cells can easily be identified and 
removed from the chamber with micromanipula- 
tors. The use of HAT-sensitive myeloma cells is 
thus no longer necessary. While a combined elec- 
tro-hydraulic procedure was applied for the pro- 
duction of a high yield of mouse hybridoma cells 
[ 1 I], human hybridoma cells can be obtained by a 
relatively simple method based on the experimen- 
tal observation that lymphocytes do not fuse with 
one another under certain field conditions. Using a 
larger percentage of lymphocytes to myeloma 
cells, myeloma-lymphocyte formation is favoured 
and a good yield of hybridoma cells can be 
achieved. 
2. MATERIALS AND METHODS 
Mononuclear cells from healthy adults were sep- 
arated by density gradient centrifugation (Ficoll, 
Pharmacia, Uppsala) [ 121. The T-lymphocytes pres- 
ent in the resulting cell suspension were largely re- 
moved by gradient centrifugation after rosetting 
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with sheep erythrocytes. Plastic-adhering cells 
were separated by incubation in a plastic Petri 
dish. Any T-cells remaining in the suspension were 
lysed by incubation with OKT 3 (Orthomune no. 
96 08 11, Ortho Diagnostic Systems GmbH, 
Heidelberg) and rabbit serum as the complement 
source 1131. Using this method, OkIa-positive cells 
were enriched to 90-95%. 
The myeloma cells (L363) were kindly supplied 
by Professor V. Diehl (Dept. Haematology, Medi- 
cal School, Hannover). This cell line was shown to 
expose only immunoglobulin light chains (type h) 
on its surface but does not secrete any measurable 
amount of immunoglobulin into the supernatant. 
The experimental set-up for electro-fusion is de- 
tailed in [8]. Briefly, platinum wires (diam. 
0.2 mm) were mounted parallel on a perspex slide 
and connected to a function generator (type 7404 
P, Toellner Electronic, G. Werner, Frankfurt) 
which was used as the voltage source for the gener- 
ation of alternating electric fields (resulting in di- 
electrophoresis and pearl chain formation [14]. A 
pulse generator (type 214 B, Hewlett Packard, 
Boeblingen) was linked in parallel for the injection 
of square pulses into the cell suspension (leading 
to electrical breakdown of the membrane). A drop- 
let of the suspensions containing myeloma cells 
(L363) and B-lymphocytes in a 1:5 ratio, sus- 
pended in 0.3 M mannitol solution with 0.5 mg/ml 
pronase (Serva GmbH, Heidelberg), was pipetted 
between the electrodes prior to field application. 
After the collection of the cells by di- 
electrophoresis (frequency of the AC field: 2 MHz, 
100 V/cm amplitude), 2 square pulses of high in- 
tensity and short duration (3.5 kV/cm, 7 ps dura- 
tion) were applied, resulting in the electrical break- 
down of the cell membranes followed by cell fu- 
sion. The procedure was carried out under sterile 
conditions in a laminar airflow cleanbench. 
Three minutes after the field application, the 
AC field was switched off, and the cells were trans- 
ferred onto microtitration plates which contained a 
0.3 M mannitol solution heated to 37°C. After a 
further 30 min a physiological NaCl solution was 
added which contained 1 mM CaC12 and 
1 mM MgCl2. The hybrid cells were cultivated on 
a feeder layer of human macrophages with 
DMEM and 20% FCS. 
To ascertain the DNA-content of the cells, the 
individual cell populations, the cell mixtures, as 
well as the hybrid populations were examined with 
a cytofluorograph (System 3OL, Ortho Instruments 
Inc. Raritan NY) around 10 h after field applica- 
tion. For this purpose the cells were stained with 
acridine orange. 
The identity of hybridoma cells was demon- 
strated after 3 weeks of cultivation by the indirect 
immunofluorescence technique using monoclonal 
anti-Ia sera (no. 96 08 61, Ortho Diagnostic Sys- 
tems GmbH, Heidelberg) and fluorescein-conju- 
gated anti-mouse Ig (code F 232, Dako Diag- 
nostika, Boehringer Ingelheim). 
3. RESULTS AND DISCUSSION 
Pearl chain formation of myeloma cells and 
lymphocytes was induced by application of the AC 
field in the fusion chamber. These chains consist of 
different combinations of myeloma cells and lym- 
phocytes. An electrical breakdown pulse (3.5 kV/ 
cm, 7 ps duration) does not lead to fusion of the 
lymphocytes with one another under these experi- 
mental conditions. In contrast, myeloma cells easi- 
ly fuse with one another and with lymphocytes. 
The lack of lymphocyte/lymphocyte fusion may 
be due to the smaller radius of these cells [9] and/ 
or to the different properties of the cell membrane 
or of the cytoskeleton. Formation of myeloma/ 
myeloma combinations could be largely avoided 
by mixing the 2 cell types in a 5: 1 ratio. This ratio 
ensures that almost every myeloma cell has contact 
with a lymphocyte. 
The electro-fusion of human B-lymphocytes 
with human myeloma cells (L363) gave a high 
yield of hybridoma cells (fig. 1). These cells became 
round within 10 min of application of the break- 
down pulse, and this process was accelerated by 
the addition of mannitol solution warmed to 37°C. 
The hybridised cells could thus be transferred to 
culture media after a further 30 min. Under the 
specified cultural conditions, hybridoma cells went 
through 3 asynchronous phases of division (tig.2) 
within 3 weeks, and the first division was observed 
after 4 days. 
In order to identify the hybridoma cells, the cells 
were stained with acridine orange [ 151 after 10 h 
cultivation, and their DNA content was examined 
with a cytofluorograph. As a control, the individu- 
al populations of peripheral blood lymphocytes 
and myeloma cells as well as mixtures of the two 
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Fig.l.(a-e) Electric field induced fusion between a human B-lymphocyte and a human myeloma cell (L363). Lympho- 
cyte and myeloma cell are brought in close membrane contact by dielectrophoresis. Pronase (0.5 mg/ml) was added to 
the suspension prior to the experiment. Photographs show the time course of fusion: (a) 10 s; (b) 20 s; (c) 40 s; (d) 60 s; 
(e) 120 s after the application of 2 square pulses (3.5 kV/cm, 7 ps). Bar: 10 pm. 
cell types not subjected to the electrical field were 
examined at the same time and under the same 
conditions. 
The results are shown in tig.3a-d. The DNA 
content is plotted as a function of the number of 
cells for B-lymphocytes in Iig.3a, for myeloma cells 
in Iig.3b, for the mixture in fig.3~ and for the 
hybridoma cells in fig.3d. 
The B-cell enriched polyclonal lymphocyte frac- 
tion is characterised by a peak with a narrow base 
which is attributable to diploid cells in the Gl and 
GO-phases. In the case of lymphocytes, the propor- 
tion of cells in the S-phase is small, as no sig- 
nificant numbers appear in this region of the histo- 
gram (fig.3a). In contrast, the myeloma cell line 
Fig.2. Hybridoma cells obtained by electro-fusion and 
cultivated on a feederlayer of human macrophages with 
DMEM and 20% FCS went through asynchronous pha- 
ses of division during the course of 3 weeks. First divi- 
sion of the hybridoma cells was observed after 4 days. 
Bar: 20 pm. 
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L363 demonstrates a peak with a broad base which 
corresponds to the GO/Gl-phase. Due to the S- 
phase in cultured cells, an elevated plateau is ob- 
served compared with the B-lymphocyte graph, 
this distribution being typical of fast-growing cells 
1161. The mixture of lymphocytes and myeloma 
cells exhibits clearly a two-peaked distribution, as 
expected from the linear superposition of the fluo- 
rescence pattern of the two cell types. Fig.3d shows 
only a single peak and a slight shoulder (arrow), 
which probably represents non-fused B-lympho- 
cytes. In addition, due to the absence of the ele- 
vated plateau on the right of the curve, it can be 
argued that there must be a new cell population. 
This population can be attributed to hybridised 
cells. 
However, one cannot rule out the possibility that 
this peak may be the result of myeloma cells with a 
low DNA content fusing with one another. This 
possibility could be disregarded by measurement 
of the DNA content as a function of the cell size. 
This relationship is shown in fig.3e for the mixture 
and in Iig.3f for the hybridoma cells. A compari- 
son of the two figures reveals the presence of a 
population which is not detectable in the original 
cell populations. This population not only exhibits 
a totally different volume distribution from its par- 
ent cells, but is also characterised by a more ho- 
mogeneous DNA distribution. It therefore seems 
reasonable to assume that this population can be 
attributed to hybridised cells. The volume of the 
hybrids indicates that fusion between 2 cells oc- 
curred, if the wide distribution in volume of the 
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Fig3.(a-d) Cytofluorographs showing the relative DNA content of different cell populations: (a) B-lymphocytes; (b) 
L363 myeloma cells; (c) a mixture of B-lymphocytes and L363 myeloma cells; (d) hybridoma cells taken 10 h after 
electro-fusion. The position of each dot indicates the intensity of green fluorescence (DNA-content) for a single cell. 
For details see text. 
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Fig,3.(e-f) Cytofluorographs representing the relative DNA content (green fluorescence intensity) as a function of the 
cell size: (e) mixture of B-lymphocytes and L 363 myeloma cells; (f) hybridoma cells, taken 10 h after electro-fusion. 
For details see text. 
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